Investor evening

20 December 2016

Venture Life Group plc

("Venture Life", the "Company" or the "Group")

Investor evening

Venture Life (AIM: VLG), the international consumer self-care group focused on developing, manufacturing and commercialising products for the ageing population, announces that it will be hosting a presentation for investors on the afternoon of Thursday 26 January 2017.

Jerry Randall, CEO will provide an overview of the Company and where it is currently positioned. The afternoon will also feature presentations by:

· Mr Vincent Poujardieu, Vice President of Rasio Group plc and General Manager of the Benecol Division. Vincent will be speaking about Benecol and the benefits the brand offers as a functional food and a food supplement.

· Mr Gianluca Braguti, founder of Biokosmes and Development and Manufacturing Director at Venture Life. Gianluca will be speaking about the new products developed at Biokosmes, including new Benecol products, to be launched in 2017 by Venture Life.

· Dr Mervyn Druian, Aesthetic Dentist. Mervyn originally brought the UltraDEX product to the UK more than 20 years ago. He has successfully used UltraDEX long term in his clinic in Primrose Hill, and will be speaking about the benefits of UltraDEX for his patients and the advantages it offers over the competition.

· Mr Tim Scott, UK Sales Director, Venture Life. Tim has recently joined Venture Life and has extensive experience in the UK retail pharmacy space. Tim will talk about the UK market trends in both the pharmacy and grocery sector and also about the commercial opportunity for UltraDEX in the UK.

The presentation will be held at the offices of Panmure Gordon, One New Change, London EC4M 9AF. The event will begin at 3pm, and after brief presentations, drinks and canapes will be served to allow guests to talk further with the speakers.

Space is limited so please register your interest, please contact venturelife@walbrookpr.com or call 020 7933 8780.

No new material or trading information will be provided.

For further information please contact: